Acceptability of a trial of vaginal progesterone for the prevention of preterm birth among HIV-infected women in Lusaka, Zambia: A mixed methods study.

Antenatal progesterone prevents preterm birth (PTB) in women with a short cervix or prior PTB in daily vaginal or weekly injectable formulations, respectively. Neither has been tested for the indication of maternal HIV, which is associated with an elevated risk of PTB. The Vaginal Progesterone (VP)...

Full description

Bibliographic Details
Main Authors: Joan T Price, Chileshe M Mabula-Bwalya, Bethany L Freeman, Jessica Carda-Auten, Winifreda M Phiri, Kasapo Chibwe, Patricia Kantumoya, Bellington Vwalika, Jeffrey S A Stringer, Carol E Golin
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2020-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0238748